These findings indicate a differential cellular response to statin-induced YAP/TAZ phosphorylation, which may underlie variations in statin sensitivity between mesenchymal and epithelial NSCLC phenotypes. This evidence concerns the gene WWTR1 and non-small cell lung carcinoma.